Saumik Biswas

Saumik Biswas


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2019 in Diabetologia
Verified
Journal Article
Closed access
PDF file
ATAnu A. Thomas
Anu A. Thomas
SBSaumik Biswas
Saumik Biswas
BFBiao Feng
Biao Feng
SCShali Chen
Shali Chen
JGJohn Gonder
John Gonder
Subrata ChakrabartiSubrata Chakrabarti
Subrata Chakrabarti

25 April 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SBSaumik Biswas
Saumik Biswas
ATAnu Alice Thomas
Anu Alice Thomas
SCShali Chen
Shali Chen
EAErfan Aref-Eshghi
Erfan Aref-Eshghi
BFBiao Feng
Biao Feng
Subrata ChakrabartiSubrata Chakrabarti
Subrata Chakrabarti
Despite possessing limited protein-coding potential, long non-coding RNAs (lncRNAs) have been implicated in a myriad of pathologic conditions. Most well documented in cancer, one prominent intergenic lncRNA known as MALAT1 is notorious for its role in impacting epigenetic mechanisms. In this study, we established a novel epigenetic paradigm for MALAT in diabetic retinopathy (DR) by employing siRNA-mediated MALAT1 knockdown in human retinal endothelial cells (HRECs), a Malat1 knockout animal model, vitreous humor from diabetic patients, pharmacological inhibitors for histone and DNA methylation, RNA immunoprecipitation, western blotting, and a unique DNA methylation array to determine glucose-related alterations in MALAT1. Our findings indicated that MALAT1 is capable of impacting the expressions of inflammatory transcripts through its association with components of the PRC2 complex in diabetes. Furthermore, the vitreous humors from diabetic patients revealed increased expressions of MALAT1, TNF-α, and IL-6. Intriguingly, our DNA methylation array demonstrated that transient high glucose exposure in HRECs does not contribute to significant methylation alterations at CpG sites across the MALAT1 gene. However, global inhibition of DNA methyltransferases induced significant increases in MALAT1 and associated inflammatory transcripts in HRECs. Our findings collectively demonstrate the importance of MALAT1 in inflammation and epigenetic regulation in DR.

Verified
Journal Article
Open access
PDF file
SBSaumik Biswas
Saumik Biswas
MSMarie Sarabusky
Marie Sarabusky
Subrata ChakrabartiSubrata Chakrabarti
Subrata Chakrabarti
Diabetic retinopathy (DR) is reaching epidemic levels globally due to the increase in prevalence of diabetes mellitus (DM). DR also has detrimental effects to quality of life, as it is the leading cause of blindness in the working-age population and the most common cause of vision loss in individuals with DM. Over several decades, many studies have recognized the role of inflammation in the development and progression of DR; however, in recent years, accumulating evidence has also suggested that non-coding RNAs, especially long non-coding (lncRNAs), are aberrantly expressed in diabetes and may play a putative role in the development and progression of DR through the modulation of gene expression at the transcriptional, post-transcriptional, or epigenetic level. In this review, we will first highlight some of the key inflammatory mediators and transcription factors involved in DR, and we will then introduce the critical roles of lncRNAs in DR and inflammation. Following this, we will discuss the implications of lncRNAs in other epigenetic mechanisms that may also contribute to the progression of inflammation in DR.

18 January 2018 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
PDF file
AGAndrew Devon Gordon
Andrew Devon Gordon
SBSaumik Biswas
Saumik Biswas
BFBiao Feng
Biao Feng
Subrata ChakrabartiSubrata Chakrabarti
Subrata Chakrabarti
Summary: Objectives and Design: In this study, we examined the role of MALAT1, a highly conserved nuclear long non‐coding RNA molecule, in chronic diabetic complications affecting the heart and kidneys using both in vitro and in vivo models: human endothelial cell culture and a Malat1 knockout mice model.Results: Findings from our in vitro experiments demonstrated that MALAT1 was predominantly localized to nuclear speckles in endothelial cells and MALAT1 expression was significantly increased following incubation with high glucose in association with increased expression of inflammatory cytokines. As for our in vivo experiments, we used Malat1 knockout mice and wild‐type controls with or without streptozotocin‐induced diabetes over 2 months of follow‐up, where all of our diabetic animals showed hyperglycaemia and polyuria. Examination of cardiac and renal tissues demonstrated altered MALAT1 RNA expression in wild‐type diabetic animals. Such changes were associated with augmented production of downstream inflammatory molecules at the mRNA and protein levels. Diabetes‐induced elevations of inflammatory markers were significantly decreased in Malat1 knockout diabetic animals. In addition to transcript and protein analyses, we examined functional changes in the heart and kidneys. Organ functions were affected in the wild‐type diabetic mice but were rescued in Malat1 knockout mice.Conclusions: Taken together, findings from this study will provide direct evidence and insight into the importance of MALAT1 in the pathogenesis of chronic diabetic complications involving the heart and kidneys.

5 February 2020 in Physiological Reports
Verified
Journal Article
Open access
PDF file
JLJieting Liu
Jieting Liu
SCShali Chen
Shali Chen
SBSaumik Biswas
Saumik Biswas
NNNiharika Nagrani
Niharika Nagrani
YLYulin Li
Yulin Li
BFBiao Feng
Biao Feng
We examined the role of mitochondrial sirtuins (SIRTs) in glucose‐induced oxidative stress, EC senescence and their regulation by miRNAs by using RT‐qPCR, ELISA, Western blot, senescence‐associated β...

22 March 2019 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
SBSaumik Biswas
Saumik Biswas
Subrata ChakrabartiSubrata Chakrabarti
Subrata Chakrabarti
Management of chronic diabetic complications remains a major medical challenge worldwide. One of the characteristic features of all chronic diabetic complications is augmented production of extracellular matrix (ECM) proteins. Such ECM proteins are deposited in all tissues affected by chronic complications, ultimately causing organ damage and dysfunction. A contributing factor to this pathogenetic process is glucose-induced endothelial damage, which involves phenotypic transformation of endothelial cells (ECs). This phenotypic transition of ECs, from a quiescent state to an activated dysfunctional state, can be mediated through alterations in the synthesis of cellular proteins. In this review, we discussed the roles of non-coding RNAs, specifically microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), in such processes. We further outlined other epigenetic mechanisms regulating the biogenesis and/or function of non-coding RNAs. Overall, we believe that better understanding of such molecular processes may lead to the development of novel biomarkers and therapeutic strategies in the future.